Abstract
Background
Transanal advancement flap repair (TAFR) is useful in the treatment of high transsphincteric fistulas. Initially, promising results were reported. More recent studies have indicated that TAFR fails in one out of three patients. In almost all of our patients with a failure, we have observed healing of the flap except at the site of the original internal opening. A possible explanation for this remarkable finding might be persistent inflammation in the fistulous tract, finding a way out through the original internal opening. The question is whether obliteration of the fistulous tract by local installation at a surgical adhesive, can prevent persistent inflammation to break through the original opening. The aim of this pilot study was to investigate whether concomitant instillation of BioGlue could improve the healing rate following TAFR for high transsphincteric fistulas.
Methods
Between March 2006 and April 2006 a consecutive series of eight patients (four men, four women; median age 46 years) with a high transsphincteric fistula underwent TAFR after instillation of BioGlue in the fistulous tract. All patients were seen in the outpatient department for postoperative evaluation.
Results
Fistula healing was observed in only one patient (12.5%). All other patients experienced one or more of the following complications: prolonged severe pain (n=5), discharge of great amounts of purulent liquid from the external opening (n=3) and abscess formation (n=2), necessitating incision and drainage. Because of this unexpected outcome we decided to terminate the study prematurely.
Conclusions
Our findings indicate that obliteration of the fistulous tract with BioGlue adversely affects the outcome of TAFR for high transsphincteric fistulas.
Similar content being viewed by others
References
Wedell J, Meier zu Eissen P, Banzhaf G, Kleine L (1987) Sliding flap advancement for the treatment of high level fistulae. Br J Surg 74:390-91
Oh C (1983) Management of high recurrent anal fistula. Surgery 93:330-32
Kodner IJ, Mazor A, Shemesh EI et al (1993) Endorectal advancement flap repair of rectovaginal and other complicated anorectal fistulas. Surgery 114:682-89
Aguilar PS, Plasencia G, Hardy TG Jr et al (1985) Mucosal advancement in the treatment of anal fistula. Dis Colon Rectum 28:496-98
Miller GV, Finan PJ (1998) Flap advancement and core fistulectomy for complex rectal fistula. Br J Surg 85:108-10
Schouten WR, Zimmerman DD, Briel JW (1999) Transanal advancement flap repair of transsphincteric fistulas. Dis Colon Rectum 42:1419-422
Sonoda T, Hull T, Piedmonte MR, Fazio VW (2002) Outcomes of primary repair of anorectal and rectovaginal fistulas using the endorectal advancement flap. Dis Colon Rectum 45:1622-628
van der Hagen SJ, Baeten CG, Soeters PB, van Gemert WG (2006) Long-term outcome following mucosal advancement flap for high perianal fistulas and fistulotomy for low perianal fistulas: recurrent perianal fistulas: failure of treatment or recurrent patient disease? Int J Colorectal Dis 21:784-90
van der Hagen SJ, Baeten CG, Soeters PB et al (2005) Staged mucosal advancement flap for the treatment of complex anal fistulas: pretreatment with noncutting Setons and in case of recurrent multiple abscesses a diverting stoma. Colorectal Dis 7:513-18
Zimmerman DD, Delemarre JB, Gosselink MP et al (2003) Smoking affects the outcome of transanal mucosal advancement flap repair of trans-sphincteric fistulas. Br J Surg 90:351-54
Mizrahi N, Wexner SD, Zmora O et al (2002) Endorectal advancement flap: are there predictors of failure? Dis Colon Rectum 45:1616-621
Ellis CN, Clark S (2006) Fibrin glue as an adjunct to flap repair of anal fistulas: a randomized, controlled study. Dis Colon Rectum 49:1736-740
van Koperen PJ, Wind J, Bemelman WA, Slors JF (2008) Fibrin glue and transanal rectal advancement flap for high transsphincteric perianal fistulas; is there any advantage? Int J Colorectal Dis 23:697-01
de la Portilla F, Rada R, Leon E et al (2007) Evaluation of the use of BioGlue in the treatment of high anal fistulas: preliminary results of a pilot study. Dis Colon Rectum 50:218-22
Herget GW, Kassa M, Riede UN et al (2001) Experimental use of an albumin-glutaraldehyde tissue adhesive for sealing pulmonary parenchyma and bronchial anastomoses. Eur J Cardiothorac Surg 19:4-
Hewitt CW, Marra SW, Kann BR et al (2001) BioGlue surgical adhesive for thoracic aortic repair during coagulopathy: efficacy and histopathology. Ann Thorac Surg 71:1609-612
Coselli JS, Bavaria JE, Fehrenbacher J et al (2003) Prospective randomized study of a protein-based tissue adhesive used as a hemostatic and structural adjunct in cardiac and vascular anastomotic repair procedures. J Am Coll Surg 197:243-52
Hidas G, Kastin A, Mullerad M et al (2006) Sutureless nephronsparing surgery: use of albumin glutaraldehyde tissue adhesive (BioGlue). Urology 67:697-00
Kumar A, Maartens NF, Kaye AH (2003) Evaluation of the use of BioGlue((R)) in neurosurgical procedures. J Clin Neurosci 10:661-64
Sidle DM, Loos BM, Ramirez AL et al (2005) Use of BioGlue surgical adhesive for brow fixation in endoscopic browplasty. Arch Facial Plast Surg 7:393-97
Tansley P, Al-Mulhim F, Lim E et al (2006) A prospective, randomized, controlled trial of the effectiveness of BioGlue in treating alveolar air leaks. J Thorac Cardiovasc Surg 132:105-12
Zehr KJ (2007) Use of bovine albumin-glutaraldehyde glue in cardiovascular surgery. Ann Thorac Surg; 84:1048-052
Biggs G, Hafron J, Feliciano J, Hoenig DM (2005) Treatment of splenic injury during laparoscopic nephrectomy with BioGlue, a surgical adhesive. Urology 66:882
Abbas MA, Tejirian T (2008) Bioglue for the treatment of anal fistula is associated with acute anal sepsis. Dis Colon Rectum. DOI: 10.1007/s10350-008-9332-2
Furst W, Banerjee A (2005) Release of glutaraldehyde from an albumin-glutaraldehyde tissue adhesive causes significant in vitro and in vivo toxicity. Ann Thorac Surg 79:1522-528
Klimo P Jr, Khalil A, Slotkin JR et al (2007) Wound complications associated with the use of bovine serum albumin-glutaraldehyde surgical adhesive in pediatric patients. Neurosurgery 60:305-09
Erasmi AW, Sievers HH, Wolschlager C (2002) Inflammatory response after BioGlue application. Ann Thorac Surg 73:1025-026
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Alexander, S.M., Mitalas, L.E., Gosselink, M.P. et al. Obliteration of the fistulous tract with BioGlue® adversely affects the outcome of transanal advancement flap repair. Tech Coloproctol 12, 225–228 (2008). https://doi.org/10.1007/s10151-008-0425-7
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10151-008-0425-7